Stay updated on Pembrolizumab vs Placebo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedA new release entry for Revision: v3.6.3 was added to the history and the entry for Revision: v3.6.0 was removed. This represents an update to the site's revision log rather than changes to core study data.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe history now shows that recruitment is closed ('No longer looking for participants'), and the changes include adding the revision tag v3.6.0 while removing the previous tag v3.5.5.SummaryDifference0.2%

- Check30 days agoChange DetectedA new revision tag, v3.5.5, was added to the history and the previous tag, v3.5.4, was removed, updating the history to reflect the latest site version labeling.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page’s revision label was updated from v3.5.3 to v3.5.4, reflecting a software version update for the ClinicalTrials.gov record history interface.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page’s revision/version indicator was updated from **v3.5.0** to **v3.5.3**, reflecting a ClinicalTrials.gov site release rather than a change to the trial record details.SummaryDifference0.1%

- Check109 days agoChange DetectedStudy status updated to Completed as of 2026-03-17, and recruitment status updated on 2026-02-23 under revision v3.5.0. The previous status 'Active, not recruiting' was removed under revision v3.4.3.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab vs Placebo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in NSCLC Clinical Trial page.